Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
5.43
Jul 10 • 04:00PM ET Dollar change+0.23 Percentage change(4.42%)
Index
RUT
Market Cap
144.09M
Enterprise Value
131.19M
Income
-52.66M
Sales
59.07M
Book/sh
1.10
Cash/sh
2.72
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
223
IPO
Jun 30, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
2.44
P/B
4.93
P/C
1.99
P/FCF
-
EV/EBITDA
-
EV/Sales
2.22
Quick Ratio
8.89
Current Ratio
10.20
Debt/Eq
2.04
LT Debt/Eq
2.03
Option/Short
Yes / Yes
EPS (ttm)
-2.01
EPS next Y
-1.90
EPS next Q
-0.52
EPS this Y
3.81%
EPS next Y
3.42%
EPS next 5Y
6.50%
EPS past 3/5Y
-0.43% -22.44%
Sales past 3/5Y
36.11% 56.40%
EPS Y/Y TTM
8.07%
Sales Y/Y TTM
11.73%
EPS Q/Q
6.43%
Sales Q/Q
19.61%
Insider Own
43.53%
Insider Trans
0.27%
Inst Own
28.87%
Inst Trans
-2.52%
ROA
-45.93%
ROE
-106.96%
ROIC
-59.74%
Gross Margin
84.87%
Oper. Margin
-84.62%
Profit Margin
-89.15%
SMA20
3.16%
SMA50
-6.21%
SMA200
-28.30%
Trades
Shs Outstand
26.43M
Shs Float
14.98M
52W High
11.30 -51.95%
52W Low
4.37 24.25%
Volatility
6.66% 7.46%
ATR (14)
0.41
RSI (14)
48.96
Beta
0.81
Rel Volume
0.43
Avg Volume
327.05K
Volume
140,461
Perf Week
-3.04%
Perf Month
4.42%
Perf Quarter
-27.41%
Perf Half Y
-33.94%
Perf YTD
-23.52%
Perf Year
-21.98%
Perf 3Y
-59.96%
Perf 5Y
-70.71%
Perf 10Y
-
Prev Close
5.20
Price
5.43
Change
4.42%
Date Action Analyst Rating Change Price Target Change
May-09-25Downgrade JP Morgan Neutral → Underweight $7
Jan-14-25Upgrade William Blair Mkt Perform → Outperform
Sep-10-24Initiated Cantor Fitzgerald Overweight $14
Jul-11-24Reiterated Lake Street Buy $18 → $12
May-01-24Resumed Craig Hallum Buy $30 → $23
May-01-24Downgrade William Blair Outperform → Mkt Perform
May-01-24Downgrade JP Morgan Overweight → Neutral $36 → $13
Jan-31-23Initiated Lake Street Buy $20
Jul-18-22Initiated Craig Hallum Buy $15
Jul-26-21Initiated William Blair Outperform
Jun-09-26 07:30AM
May-27-26 04:30PM
May-20-26 04:30PM
May-14-26 08:00AM
May-12-26 03:06AM
04:50PM Loading…
May-11-26 04:50PM
04:05PM
May-08-26 09:18AM
May-04-26 04:30PM
Apr-27-26 04:30PM
Apr-20-26 04:30PM
Apr-13-26 08:00AM
Mar-02-26 08:30AM
Feb-15-26 08:01PM
Feb-13-26 08:30AM
06:19PM Loading…
Feb-12-26 06:19PM
05:30PM
04:28PM
04:05PM
Feb-11-26 07:35AM
Jan-29-26 04:10PM
Jan-23-26 12:33PM
Jan-22-26 04:05PM
Jan-12-26 08:00AM
Jan-06-26 08:30AM
Dec-22-25 08:30AM
Nov-19-25 08:30AM
Nov-06-25 12:03AM
Nov-05-25 07:10PM
06:06PM
04:05PM Loading…
04:05PM
Nov-04-25 08:37AM
08:30AM
Oct-22-25 04:30PM
Aug-05-25 03:04AM
Aug-04-25 05:20PM
04:16PM
04:05PM
Jul-30-25 10:00AM
Jul-29-25 08:30AM
Jul-28-25 10:00AM
Jul-21-25 04:30PM
Jul-17-25 04:58AM
Jul-16-25 07:30AM
May-28-25 04:30PM
May-09-25 03:40AM
May-08-25 06:35PM
05:27PM
04:05PM
May-07-25 11:20AM
May-06-25 10:00AM
May-01-25 10:01AM
Apr-24-25 04:30PM
Apr-09-25 08:45AM
Apr-07-25 04:05PM
Feb-12-25 02:45PM
Feb-11-25 09:55AM
Feb-07-25 09:55AM
Feb-05-25 02:14AM
Feb-04-25 05:45PM
04:49PM
04:05PM
Feb-03-25 07:08AM
Jan-21-25 04:30PM
Jan-16-25 10:00AM
Jan-13-25 08:00AM
Dec-23-24 04:30PM
Nov-26-24 08:31AM
Nov-20-24 04:30PM
Nov-04-24 08:00AM
Oct-30-24 03:14AM
Oct-29-24 05:50PM
04:46PM
04:05PM
Oct-28-24 09:08AM
Oct-21-24 08:42AM
06:40AM
Oct-19-24 02:10PM
Oct-18-24 02:08PM
Oct-15-24 04:30PM
Sep-12-24 10:13AM
08:00AM
Sep-03-24 08:30AM
Aug-26-24 09:00PM
Aug-05-24 07:22PM
05:20PM
Aug-02-24 08:00AM
Jul-31-24 04:27PM
Jul-29-24 05:40PM
04:38PM
04:05PM
Jul-15-24 04:30PM
Jul-12-24 11:54AM
Jun-25-24 06:50AM
Jun-06-24 05:48AM
May-22-24 08:30AM
May-16-24 07:30AM
May-01-24 10:45AM
08:39AM
07:42AM
CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It operates through the following geographical segments: United States, Germany, and Other Countries. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2001 and is headquartered in Minneapolis, MN.
PresidentMr. Kevin Hykes
M.Sc.Dr. Philip B. Adamson M.D.
Chief Revenue OfficerMr. Robert Allen John
Chief Financial OfficerMr. Jared Oasheim
Chief Operating OfficerMr. Brent Binkowski
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Adamson Philip B.Chief Medical OfficerMar 02 '26Sale7.901,2629,97361,578Mar 16 04:16 PM
Hykes KevinPRES & CEOMar 02 '26Sale7.907,76361,349284,237Mar 03 06:03 PM
VERRASTRO PAULCHIEF MKTG & STRAT OFFICERMar 02 '26Sale7.901,28410,14660,551Mar 03 06:03 PM
OASHEIM JAREDCHIEF FINANCIAL OFFICERMar 02 '26Sale7.901,74413,78196,703Mar 03 06:02 PM
John Robert AllenChief Revenue OfficerMar 02 '26Sale7.903,96431,32686,036Mar 03 06:01 PM
Jain Mudit K.DirectorFeb 20 '26Buy6.3646,800297,592980,183Feb 23 06:00 AM
Jain Mudit K.DirectorFeb 18 '26Buy4.646002,7855,650Feb 18 05:22 PM
JOHNSON & JOHNSON10% OwnerNov 26 '25Sale10.036,33763,5604,040,861Dec 01 04:07 PM
JOHNSON & JOHNSON10% OwnerNov 24 '25Sale10.062,20022,1324,047,198Nov 25 12:54 PM
JOHNSON & JOHNSON10% OwnerNov 21 '25Sale10.005005,0004,049,398Nov 25 12:54 PM
JOHNSON & JOHNSON10% OwnerNov 12 '25Sale10.001,00010,0004,049,898Nov 14 03:07 PM
JOHNSON & JOHNSON10% OwnerNov 06 '25Sale10.2152,332534,3104,051,098Nov 10 03:28 PM
JOHNSON & JOHNSON10% OwnerNov 07 '25Sale10.002002,0004,050,898Nov 10 03:28 PM